Federal award
ROCHE DIAGNOSTICS CORPORATION
W81K0221P0096
Contract
Obligated and Ceiling
- Obligated (net)
- $1,588,276.31
- Ceiling (potential value, not spending)
- $1,588,276.31
- Current value
- $1,588,276.31
- Gross positive obligations
- $1,853,322.38
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ROCHE HOLDING AG · WJHDT127L353
- Awarding agency
- Department of War · sub-agency 97DH · office HT9410
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0221P0096
- Award type code
- B
- Actions
- 20 · Jun 24, 2021 to May 7, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History20
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| May 7, 2026 | FY2026 | P00019 | M | $0.00 | — |
| Apr 7, 2026 | FY2026 | P00018 | M | $0.00 | — |
| Sep 25, 2025 | FY2025 | P00017 | B | $19,906.26 | — |
| Mar 26, 2025 | FY2025 | P00016 | F | −$124,091.61 | — |
| Nov 25, 2024 | FY2025 | P00015 | C | $399,042.75 | — |
| Sep 25, 2024 | FY2024 | P00014 | B | $215,000.00 | — |
| Sep 10, 2024 | FY2024 | P00013 | B | −$0.11 | — |
| Jul 30, 2024 | FY2024 | P00012 | G | $0.00 | — |
| Jul 25, 2024 | FY2024 | P00011 | B | $2,459.00 | — |
| Oct 17, 2023 | FY2024 | P00010 | C | $384,288.75 | — |
| Aug 3, 2023 | FY2023 | P00009 | G | $0.00 | — |
| Jun 16, 2023 | FY2023 | P00008 | M | $0.00 | — |
| Mar 20, 2023 | FY2023 | P00007 | B | −$76,906.23 | — |
| Dec 27, 2022 | FY2023 | P00006 | B | $0.00 | — |
| Nov 18, 2022 | FY2023 | P00005 | C | $384,288.75 | — |
| May 5, 2022 | FY2022 | P00004 | G | $0.00 | — |
| Feb 9, 2022 | FY2022 | P00003 | B | −$64,048.12 | — |
| Nov 8, 2021 | FY2022 | P00002 | C | $384,288.75 | — |
| Jul 26, 2021 | FY2021 | P00001 | G | $0.00 | — |
| Jun 24, 2021 | FY2021 | 0 | — | $64,048.12 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.